 | Curcumin | IC50 | 9900.0 [1] |
 | 4-(6-Iodo-2-imidazo[1,2-a]pyridinyl)-N,N-dimethylaniline | Ki | 3.05 [1], 15.0 [2] |
 | 2-(4-(Methylamino)phenyl)benzo[d]thiazol-6-ol | IC50 | 19.0 [1] |
 | Resveratrol | IC50 | 11890.0 [1] |
 | 2-[4-(Dimethylamino)phenyl]-3,6-dimethyl-1,3-benzothiazol-3-ium | Ki | 294.0 [1], 4000.0 [2] |
 | Sodium | IC50 | 1300.0 [1], 3000.0 [2], 8700.0 [3] |
| Sodium | Ki | 1000.0 [1] |
 | (1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one | IC50 | 3900.0 [1] |
| (1E,4Z,6E)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,4,6-trien-3-one | Ki | 0.21 [1] |
 | Chrysamine G | Ki | 0.14 [1], 0.4 [2], 1000.0 [3], 2000.0 [4] |
 | 4-(4-(Methylamino)styryl)phenol | Ki | 1.2 [1] |
 | Florbetapir (18F) | Ki | 2.87 [1], 2.9 [2] |
 | (-)-Epigallocatechin gallate | IC50 | 500.0 [1], 3000.0 [2], 4600.0 [3], 100000.0 [4] |
 | Florbetaben F-18 | Ki | 2.2 [1], 2.22 [2] |
 | 5-[(E)-2-[4-[(E)-2-(3-Carboxy-4-methoxyphenyl)ethenyl]-3-iodophenyl]ethenyl]-2-methoxybenzoic acid | Ki | 0.8 [1], 5.1 [2], 1000.0 [3] |
 | 2-N-Benzylquinazoline-2,4-diamine | IC50 | 2200.0 [1], 8400.0 [2] |
 | Quercetin | IC50 | 7940.0 [1], 15300.0 [2], 124600.0 [3] |
 | Myricetin | IC50 | 3000.0 [1], 14800.0 [2], 15100.0 [3] |
 | Fddnp | Ki | 152.0 [1], 172.0 [2], 8000.0 [3] |
 | 2-[4-(Dimethylamino)phenyl]-6-iodobenzothiazole | Ki | 0.9 [1], 2.2 [2], 5000.0 [3] |
 | 4-(6-Bromo-1,3-benzothiazol-2-yl)-N,N-dimethylaniline | Ki | 0.8 [1], 2.9 [2], 3000.0 [3] |
 | N~2~-(2-Phenylethyl)quinazoline-2,4-diamine | IC50 | 14900.0 [1], 25000.0 [2] |
 | N4-Benzylquinazoline-2,4-diamine | IC50 | 4800.0 [1], 25000.0 [2] |
 | 4-N-(2-Phenylethyl)quinazoline-2,4-diamine | IC50 | 7800.0 [1], 25000.0 [2] |
 | CID 72714844 | IC50 | 3.1 [1], 4.5 [2], 92.0 [3] |
 | Edetic acid | IC50 | 7700.0 [1], 28400.0 [2] |
 | Chloroquine | IC50 | 7000.0 [1], 12800.0 [2] |
 | Nicotinic acid | IC50 | 13100.0 [1], 43700.0 [2] |
 | Apigenin | IC50 | 23000.0 [1], 176200.0 [2] |
 | Kaempferol | IC50 | 75100.0 [1] |
 | Amodiaquine | IC50 | 4000.0 [1], 5400.0 [2] |
 | Flutemetamol F-18 | Ki | 0.7 [1], 0.74 [2] |
 | Flutemetamol | IC50 | 24.0 [1] |
| Flutemetamol | Ki | 0.74 [1] |
 | Dehydrozingerone | Ki | 54.24 [1], 55.9 [2] |
 | 1-(3',4'-Dichloro-2-fluoro(1,1'-biphenyl)-4-yl)cyclopropanecarboxylic acid | IC50 | 14000.0 [1], 41000.0 [2] |
 | Memoquin | IC50 | 5930.0 [1] |
 | 2-[6-(Methylamino)pyridin-3-yl]-1,3-benzothiazol-6-ol | IC50 | 22.0 [1] |
| 2-[6-(Methylamino)pyridin-3-yl]-1,3-benzothiazol-6-ol | Ki | 1.7 [1] |
 | 4-(1,3-Benzothiazol-2-yl)-N-methylaniline | Ki | 1.28 [1], 11.0 [2] |
 | (2R)-2-[[(2S,3S)-4-[(E)-3-[(1R)-1-Carboxy-2-(3,4-dihydroxyphenyl)ethoxy]-3-oxoprop-1-enyl]-2-(3,4-dihydroxyphenyl)-6-hydroxy-2,3-dihydro-1-benzofuran-3-yl]-hydroxymethoxy]-3-(3,4-dihydroxyphenyl)propanoic acid | IC50 | 1540.0 [1], 5000.0 [2] |
 | Cyclopropanecarboxylic acid, 1-(2-fluoro-4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)- | IC50 | 22000.0 [1], 111000.0 [2] |
 | [1-[(2R,6R)-1-(4-Chlorophenyl)sulfonyl-6-ethylpiperidin-2-yl]cyclopropyl] 4-(1-hydroxy-2-methylpropan-2-yl)piperazine-1-carboxylate | IC50 | 6.9 [1], 8.3 [2] |
 | N-[3-[(7-Chloroquinolin-4-yl)amino]-5-[[2-(dimethylamino)ethylamino]methyl]phenyl]-2-piperidin-1-ylacetamide | IC50 | 2000.0 [1], 2100.0 [2] |
 | 4-[(7-Chloroquinolin-4-yl)amino]-2,6-bis(pyrrolidin-1-ylmethyl)phenol | IC50 | 5100.0 [1], 11200.0 [2] |
 | 7-Chloro-N-[3-(diethylaminomethyl)phenyl]quinolin-4-amine | IC50 | 4500.0 [1], 10400.0 [2] |
 | 5-((E)-2-{4-[(E)-2-(3-Carboxy-4-hydroxyphenyl)vinyl]-2-iodophenyl}vinyl)-2-hydroxybenzoic acid | IC50 | 8000.0 [1] |
 | CID 25233596 | Ki | 5.7 [1] |
 | [1-[(2R,6S)-1-(4-Chlorophenyl)sulfonyl-6-cyclopropylpiperidin-2-yl]cyclopropyl] 4-(1-hydroxy-2-methylpropan-2-yl)piperazine-1-carboxylate | IC50 | 12.0 [1], 39.0 [2] |
 | N-[3-[(7-Chloroquinolin-4-yl)amino]-5-(morpholin-4-ylmethyl)phenyl]-2-piperidin-1-ylacetamide | IC50 | 3100.0 [1], 7100.0 [2] |
 | 4-[Benzo(b)thiophen-2-yl]phenol | Ki | 3.04 [1], 3.72 [2] |
 | N-[3-[(7-Chloroquinolin-4-yl)amino]-5-[[2-(dimethylamino)ethyl-methylamino]methyl]phenyl]-2-piperidin-1-ylacetamide | IC50 | 1700.0 [1], 2900.0 [2] |
 | N-[3-[(7-Chloroquinolin-4-yl)amino]-5-(diethylaminomethyl)phenyl]-2-piperidin-1-ylacetamide | IC50 | 1500.0 [1], 2800.0 [2] |
 | 4-[(E)-2-[3-[(E)-2-[4-(Dimethylamino)-3-methoxyphenyl]ethenyl]phenyl]ethenyl]-2-methoxy-N,N-dimethylaniline | IC50 | 1000.0 [1] |
 | 3-N-(7-Chloroquinolin-4-yl)-5-(diethylaminomethyl)-1-N-(2-piperidin-1-ylethyl)benzene-1,3-diamine | IC50 | 10000.0 [1], 13800.0 [2] |
 | 4-(1-Benzothien-2-yl)aniline | Ki | 4.31 [1], 6.5 [2] |
 | Unii-6EL8B8Q1UH | Ki | 0.2 [1], 5.5 [2] |
 | 6-Iodo-4'-methoxyflavone | Ki | 29.0 [1], 38.3 [2] |
 | 4-[6-(2-(18F)Fluoranylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]-N-methylaniline | Ki | 2.1 [1], 3.2 [2] |
 | 2-[4-[Tritio(tritritiomethyl)amino]phenyl]-1,3-benzothiazol-6-ol | IC50 | 27.0 [1] |
| 2-[4-[Tritio(tritritiomethyl)amino]phenyl]-1,3-benzothiazol-6-ol | Ki | 2.8 [1] |
 | 4-N-[(4-Fluorophenyl)methyl]quinazoline-2,4-diamine | IC50 | 3100.0 [1], 25000.0 [2] |
 | 2-[4-(Dimethylamino)phenyl]-6-bromoimidazo[1,2-a]pyridine | Ki | 5.9 [1], 10.3 [2] |
 | 2-[4-(4-Cyclohexylphenyl)-3-fluorophenyl]propanoic acid | IC50 | 21000.0 [1], 46000.0 [2] |
 | 4-(4-Hydroxy-3-iodo-5-methoxyphenyl)-3-buten-2-one | Ki | 19.97 [1], 36.6 [2] |
 | 3H-Pyrazol-3-one, 2,4-dihydro-2-(3-methoxyphenyl)-5-methyl- | IC50 | 50000.0 [1] |
 | 1,6-Bis(4-methoxyphenyl)-1,3,5-hexatriene | Ki | 4000.0 [1], 8000.0 [2] |
 | 6-Bromo-2-[4-(4-methylpiperazin-1-yl)phenyl]-1,3-benzothiazole | Ki | 5.0 [1], 2400.0 [2] |
 | 2-[4-(4-Methylpiperazino)phenyl]-6-iodobenzothiazole | Ki | 6.4 [1], 2000.0 [2] |
 | 4-[(1E,3E,5E)-6-[4-(2-Fluoroethylamino)phenyl]hexa-1,3,5-trienyl]aniline | Ki | 12.0 [1], 217.0 [2] |
 | 4-[(1E,3E,5E)-6-(4-Aminophenyl)hexa-1,3,5-trienyl]aniline | Ki | 9.0 [1], 375.0 [2] |
 | 1-[4-[4-(4,4-Dimethylcyclohexyl)phenyl]-3-fluorophenyl]cyclopropane-1-carboxylic acid | IC50 | 46000.0 [1], 101000.0 [2] |
 | 1,6-Bis[4-(dimethylamino)phenyl]-1,3,5-hexatriene | Ki | 837.0 [1], 7000.0 [2] |
 | 2-[4-(3,5-Dichlorophenyl)-3-fluorophenyl]propanamide | IC50 | 12000.0 [1], 64000.0 [2] |
 | 2-(3',5'-Dichloro-2-fluoro-biphenyl-4-yl) propionic acid | IC50 | 77000.0 [1], 94000.0 [2] |
 | 2-(4-Dimethylaminophenyl)-6-iodo-4-chromenone | Ki | 13.2 [1], 15.6 [2] |
 | 4-[(1E,3E,5E)-6-(4-Hydroxyphenyl)hexa-1,3,5-trienyl]phenol | Ki | 9.0 [1], 150.0 [2] |
 | N-Methyl-4-[(1E,3E,5E)-6-[4-(methylamino)phenyl]hexa-1,3,5-trienyl]aniline | Ki | 7.5 [1], 122.0 [2] |
 | 1-[3-Fluoro-4-[4-(4-hydroxyphenyl)phenyl]phenyl]cyclopropane-1-carboxylic acid | IC50 | 31600.0 [1], 409000.0 [2] |
 | 6-Iodo-4'-methylaminoflavone | Ki | 22.6 [1], 30.0 [2] |
 | 2-(4-Hydroxyphenyl)-6-iodochromen-4-one | Ki | 72.5 [1], 77.2 [2] |
 | 5-Methyl-2-[3-(phenylmethoxymethyl)phenyl]-4H-pyrazol-3-one | IC50 | 2900.0 [1], 27000.0 [2] |
 | 2-[4-(4-Methoxyphenyl)phenyl]-5-methyl-4H-pyrazol-3-one | IC50 | 3400.0 [1], 5100.0 [2] |
 | 5-Methyl-2-(4-pyridin-3-ylphenyl)-4H-pyrazol-3-one | IC50 | 3900.0 [1], 14500.0 [2] |
 | 5-Methyl-2-[4-(2-phenylindol-1-yl)phenyl]-4H-pyrazol-3-one | IC50 | 3500.0 [1], 19600.0 [2] |
 | 5-Methyl-2-[4-(N-phenylanilino)phenyl]-4H-pyrazol-3-one | IC50 | 4000.0 [1], 50000.0 [2] |
 | 5-Methyl-2-(4-pyrrol-1-ylphenyl)-4H-pyrazol-3-one | IC50 | 4000.0 [1], 26000.0 [2] |
 | 5-Methyl-2-(4-phenylphenyl)-4H-pyrazol-3-one | IC50 | 5600.0 [1], 19500.0 [2] |
 | 2-N-[(3-Methoxyphenyl)methyl]quinazoline-2,4-diamine | IC50 | 25000.0 [1] |
 | 2-N-[[4-(Trifluoromethyl)phenyl]methyl]quinazoline-2,4-diamine | IC50 | 2300.0 [1], 5300.0 [2] |
 | 2-N-[(3-Fluorophenyl)methyl]quinazoline-2,4-diamine | IC50 | 11300.0 [1], 14700.0 [2] |
 | 2-N-[[3-(Trifluoromethyl)phenyl]methyl]quinazoline-2,4-diamine | IC50 | 12500.0 [1], 13800.0 [2] |
 | 2-N-[(3-Methylphenyl)methyl]quinazoline-2,4-diamine | IC50 | 25000.0 [1] |
 | 2-N-[(3-Chlorophenyl)methyl]quinazoline-2,4-diamine | IC50 | 5900.0 [1], 13400.0 [2] |
 | 4-N-[[3-(Trifluoromethyl)phenyl]methyl]quinazoline-2,4-diamine | IC50 | 3500.0 [1], 21000.0 [2] |
 | 4-N-[[4-(Trifluoromethyl)phenyl]methyl]quinazoline-2,4-diamine | IC50 | 1900.0 [1], 25000.0 [2] |
 | 2-N-[(4-Fluorophenyl)methyl]quinazoline-2,4-diamine | IC50 | 25000.0 [1] |
 | 2-N-Propan-2-ylquinazoline-2,4-diamine | IC50 | 25000.0 [1] |
Calculator
